Direct Observation of Protonation Reactions during the Catalytic Cycle of Cytochrome c Oxidase by Nyquist, R. et al.
 oxidasecDirect observation of protonation reactions during the catalytic cycle of cytochrome 
Rebecca M. Nyquist, Dirk Heitbrink, Carsten Bolwien, Robert B. Gennis, and Joachim Heberle 
doi:10.1073/pnas.1530408100 
 2003;100;8715-8720; originally published online Jul 8, 2003; PNAS




can be found at: 
High-resolution figures, a citation map, links to PubMed and Google Scholar, etc.,
 References
 www.pnas.org/cgi/content/full/100/15/8715#BIBL
This article cites 43 articles, 10 of which you can access for free at: 
 www.pnas.org/cgi/content/full/100/15/8715#otherarticles
This article has been cited by other articles: 
 E-mail Alerts
. click herethe top right corner of the article or
Receive free email alerts when new articles cite this article - sign up in the box at
 Rights & Permissions
 www.pnas.org/misc/rightperm.shtml
To reproduce this article in part (figures, tables) or in entirety, see: 
 Reprints
 www.pnas.org/misc/reprints.shtml
To order reprints, see: 
 Notes:
Direct observation of protonation reactions during
the catalytic cycle of cytochrome c oxidase
Rebecca M. Nyquist*, Dirk Heitbrink*, Carsten Bolwien*, Robert B. Gennis†, and Joachim Heberle*‡
*Forschungszentrum Ju¨lich, IBI-2: Structural Biology, 52425 Ju¨lich, Germany; and †Department of Biochemistry, University of Illinois at Urbana–Champaign,
Urbana, IL 61801
Edited by Harry B. Gray, California Institute of Technology, Pasadena, CA, and approved June 2, 2003 (received for review January 23, 2003)
Cytochrome c oxidase, the terminal protein in the respiratory
chain, converts oxygen into water and helps generate the electro-
chemical gradient used in the synthesis of ATP. The catalytic action
of cytochrome coxidase involves electron transfer, proton transfer,
and O2 reduction. These events trigger specific molecular changes
at the active site, which, in turn, influence changes throughout the
protein, including alterations of amino acid side chain orientations,
hydrogen bond patterns, and protonation states. We have used IR
difference spectroscopy to investigate such modulations for the
functional intermediate states E, R2, Pm, and F. These spectra reveal
deprotonation of its key glutamic acid E286 in the E and in the Pm
states. The consecutive deprotonation and reprotonation of E286
twice within one catalytic turnover illustrates the role of this
residue as a proton shuttle. In addition, the spectra point toward
deprotonation of a redox-active tyrosine, plausibly Y288, in the F
intermediate. Structural insights into the molecular mechanism of
catalysis based on the subtle molecular changes observed with IR
difference spectroscopy are discussed.
electron transfer  infrared attenuated total reflection  membrane
protein  bacteriorhodopsis  glutamic acid
The respiratory chain generates an electrochemical gradientwhich drives production of ATP, our immediate, most readily
available energy source. This team of enzymes governs the traffic
of protons and electrons across the inner mitochondrial mem-
brane of eukaryotes and the cytoplasmic membrane of pro-
karyotes. Cytochrome c oxidase (CcO) is the terminal respira-
tory enzyme, catalyzing the reduction of a molecule of dioxygen
to two molecules of water, consuming four protons and four
electrons. The free energy made available by this reaction is
coupled to the translocation of four additional protons (1, 2).
The active site of the enzyme is a bimetallic center consisting of
a high-spin heme and a copper. Within the heme–copper oxygen
reductase family, the electron donor, heme type, and assistant
cofactors vary. The heme–copper oxygen reductase from mito-
chondria and the prokaryotic counterparts such as the oxidase
from Rhodobacter sphaeroides employ cytochrome c as the
electron donor and hence are better known by the name CcO.
Electrons from cytochrome c are funneled into the active site via
two other cofactor sites: a two-copper site (CuA) receives single
electrons at the outer side of the membrane from cytochrome c,
and a low-spin heme (heme a) passes the electrons received from
CuA into the active site heme a3 and CuB (Fig. 1).
Electron transfers are strongly coupled to proton movements
within the enzyme. Two pathways containing hydrophilic amino
acids and internal water molecules facilitate the proton trans-
location from the bacterial cytoplasm or mitochondrial matrix
into the active site (Fig. 1). The first of these two pathways leads
to a conserved tyrosine in the active site, Y288 (numbering for
CcO from the bacterium R. sphaeroides). This tyrosine appears
to play a critical role in catalyzing the splitting of the OOO bond
by providing a proton or a hydrogen atom to O2 after it binds to
reduced heme a3 at the active site (3). If the tyrosine donates
both a proton and an electron to O2, a tyrosyl radical must form
(4, 5). Its formation correlates with the finding that in the x-ray
structures of several heme–copper oxygen reductases [Paracoc-
cus denitrificans (6), Bos taurus mitochondrial (7), and Thermus
thermophilus ba3 (8)], that the tyrosine is posttranslationally
cross-linked to a histidine that also serves as a ligand to CuB. The
second proton translocation pathway extends to a a glutamic
acid, E286 (Fig. 2),11 Å from the active site (9). Although the
role of E286 is not fully understood, the presence of a protona-
table residue at or near this position seems to form an essential
component of the proton-conducting pathway, critical for rapid
proton delivery to the active site (to form H2O) and for proton
pumping (10).
Proton and electron transfers must trigger specific molecular
changes at the active site, influencing changes throughout the
protein, including alterations of amino acid side chain orienta-
tions, hydrogen bond lengths, and protonation states. Particulars
of the coupling between electron transfer and proton pumping
remain controversial (11, 12). Solving the molecular mechanism
hinges on acquiring more detailed structural information about
the catalytic intermediates. IR spectroscopy resolves singular
proton transfer events between cofactors, amino acid side chains
and internal water molecules. The success of this technique is
demonstrated by its elucidation of the sequence of proton
transfer steps in bacteriorhodopsin, a prototypical transmem-
brane proton pump (13).
In this work, time-resolved and steady-state IR spectroscopy
were combined to observe protonation changes in a series of
CcO intermediates (Fig. 2). The first of these, O, is the state in
which all four metal cofactors are fully oxidized. Before dioxygen
binds, two electrons are received externally, passed from CuA via
heme a to the active site. Each step exhibits rigorous control:
electrons are received one at a time and key internal electron
transfer rates are limited by proton transfers. We use the terms
E and R2 to designate forms of the enzyme with one and two
electrons, respectively, in the binuclear center. Net proton
uptake from solution is evident during both O-to-E and E-to-R2
transitions (14), though the destinations and eventual fate of
these protons (e.g., pumped vs. water formation) have remained
unclear. Proton translocation takes place in the E-to-R2 transi-
tion (11). It is noted that when the enzyme is reduced by
two-electrons, the population of the enzyme with both electrons
at the binuclear center (i.e., R2) is small in the absence of a
stabilizing ligand (such as CO). Dioxygen binds to the two-
electron reduced enzyme, and rapid cleavage of the OOO bond
is performed in such way as to prevent release of harmful
partially reduced forms of O2 (5). In the reaction of R2 with
dioxygen, the first spectroscopically detectable intermediate
with partially reduced dioxygen bound to the active site is Pm.
In this state, the OOO bond has been split and one of the oxy-
gen atoms forms an oxoferryl intermediate with heme a3, i.e.,
Fe4a3AO2 (15). The heterolytic OOO bond splitting on O2
reaction with the two-electron reduced form of the enzyme
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requires an additional reducing equivalent, presumed to come
from the active site tyrosine Y288, forming a tyrosyl radical (4).
A second oxoferryl intermediate, F, is formed when an electron
is donated to Pm from an external donor, accompanied by
another proton uptake. The electron is thought to reduce the
radical formed in Pm (6). The Pm-to-F transition is almost
certainly coupled to pumping one proton (16, 17). When the F
intermediate receives an externally donated electron, the
Fe4a3AO2 species is reduced to Fe3 and the oxygen atom is
lost as a water molecule, another proton is pumped, O is
regenerated, and the cycle is completed. We recorded IR
difference spectra for three sets of intermediates of CcO from R.
sphaeroides. Differences between intermediates R2 (with bound
CO) and E were recorded by using time-resolved IR difference
spectroscopy, whereas differences between Pm and O as well as
F and O were observed with perfusion-induced IR spectroscopy.
Most previous IR experiments have focused on the vibrational
differences between the oxidized (O) and the four-electron
reduced (R4) states of the enzyme (18–20), i.e., in the absence
of dioxygen, and there is one recent report of the Pm-O differ-
ence spectrum of bovine oxidase (21). Our study is the first to
demonstrate protonation state changes of functionally relevant
amino acid side chains in states of the enzyme identified as
catalytic intermediates.
Materials and Methods
Wild-type and mutant CcO from R. sphaeroides was grown and
purified as described (22). R2CO was created by depositing 10 l
of300Moxidase in 100 mMKCl, 50 mMphosphate (pH 8.5),
0.05% dodecylmaltoside on a BaF2 cuvette, and deoxygenating
by repeated cycles of evacuation and CO exposure in a custom-
built anaerobic chamber (23). After 2 min under 1 bar CO (1
bar  100 kPa), the cuvette was sealed with a second BaF2
window. The final optical path length was 10 m. The presence
of the R2CO state was verified byUVvisible spectrophotometry
(Fig. 3). The shoulder on the band at 448 nm indicates some
overreduction after the time-resolved IR experiments. All IR
experiments were performed on an IFS 66v spectrometer
(Bruker, Rheinstetten, Germany). Photo-induced dissociation of
carbon monoxide from R2CO was achieved by a nanosecond
laser pulse (frequency doubled output from a Nd:YAG laser at
532 nm, 40 mJ per pulse per cm2, 5-Hz repetition rate). To slow
the kinetics and to ensure long-term stability of the R2CO state,
the sample was thermostated at 5°C. The trace shown represents
an average of 30,000 difference spectra recorded 30 ms after
photolysis in rapid-scan mode with an optical resolution of 4.5
cm1. IR difference spectroscopy of the Pm and F state were
performed with the attenuated total reflection (ATR) technique
(20). CcO was reconstituted with dimyristoyl-phosphatidyl-
choline (DMPC) lipids and adhered to the surface of a diamond
internal reflection element at 20°C. A flow-cell enabled ex-
change of the bathing buffer to induce Pm and F in steady-state.
Films of CcO were examined spectrophotometrically under
simulated conditions of the ATR IR experiments by drying the
protein–lipid solution onto the inner wall of a conventional 1-cm
path length quartz cuvette. The film was then immersed in
oxygenated buffer containing 50 mM phosphate, 100 mM KCl
(pH 8.5), and an O spectrum (Shimadzu UV–2101PC) was
recorded. For Pm, the buffer was saturated with CO and O2 at
pH 8.5. Likewise, fully reduced spectra were recorded in the
presence of a degassed solution of 50 mM phosphate, 90 mM
KCl, and 10 mM Na2S2O4 (pH 8.5). F was created via perfusion
with 50 mM phosphate, 1 mM H2O2 (pH 8.5) (24). The
Fig. 1. Structural view of CcO from R. sphaeroides (PDB ID 1M56; ref. 9)
parallel to the membrane surface, with periplasmic surface on top. (Left)
Ribbon diagram highlighting the arrangement of the four subunits (SU I–IV).
(Right) A view in which the protein backbone is stripped to show the chemical
structure of particularly important catalytically active groups. The gray arrows
indicate the two spatially separated proton transfer pathways that contain
the critical residues D132 and K362.
Fig. 2. Qualitative overview of the molecular steps taking place in the active
center of CcO during catalysis (adapted from refs. 9 and 37 and modified). In
the initial state, all four redox centers (CuA, heme a, heme a3, and CuB) are
oxidized (O). Successive electron input steps from cytochrome c initiate a series
of molecular changes (in red) that finally lead to oxygen cleavage (in blue) and
proton transfer across the membrane (green arrows). The first electron to the
binuclear center reduces CuB to form the E state. The uptake of a second
electron from cytochrome c reduces hemea3 (R2), and dioxygen can bind to the
central iron of heme a3. Both initial electron transfer reactions are coupled to
net proton uptake by the protein. In the Pm state, bound dioxygen is cleaved
and tyrosine 288 (Y288) is proposed to be a radical. The uptake of the third
electron with a proton forms the F state. The final step (F to O) is driven by the
uptake of the fourth electron. It is concluded from the present work that E286
is protonated in the O, R2, and F state but deprotonated in the E and the Pm
intermediate. The side chain of a tyrosine, presumed to be Y288, is a phenolate
radical in Pm, a phenolate in F but a phenol in the other states. For simplicity,
only those intermediates are included that are investigated in the present
study. Although CcO maneuvers a total of eight protons during the cycle (four
destined to form H2O and four pumped protons), stoichiometric balance of
these protons is not shown in the figure because not all proton donors and
acceptors within the protein have been identified.
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concentration of H2O2 was calibrated spectrophotometrically by
using the extinction coefficient 40 mM1cm1 at 240 nm (24).
For each intermediate, the films were cycled back to O with
several washes of unsaturated 50 mM phosphate, 100 mM KCl
(pH 8.5), and the measurements were repeated. In each case,
nine 5,000-scan cycles at an optical resolution of 2 cm1 were
averaged. Further details about the sample preparation and
spectroscopic methods have been described elsewhere (20).
Results and Discussion
The E-to-R2CO Transition. As with other hemoproteins, carbon
monoxide can be bound in place of dioxygen under anaerobic
conditions. In CcO, the binding site is the central iron of the
reduced heme a3. The visible difference spectrum (red trace in
Fig. 3A) exhibits characteristic maxima at 590 nm of the -band
and at 432 nm in the Soret region for the two-electron reduced
CO-bound state (R2CO). A fortuitous feature of the Fea3–CO
bond is that it is photolabile, hence dissociable with a laser pulse.
After photodissociation of CO from heme a3, the reduction
potential of heme a is higher relative to that of heme a3, and
electron transfer between heme a3 and heme a ensues (23).
When this occurs, a state of the enzyme is transiently created in
which the heme a3-CuB binuclear center carries only one elec-
tron, the distal heme ligand (CO) is absent, and heme a is
reduced. We refer to this as the E state. Time-resolved IR
difference spectra were acquired across the range from 4,000 to
800 cm1. The dissociation of CO from the heme a3 Fe was
monitored by the negative band at 1,967 cm1 of the C'O
stretching vibration (data not shown). This frequency is indic-
ative for the presence of the two-electron reduced state. A slight
overreduction, which appears at the end of the time-resolved
Fourier transform IR experiment (see shoulder at 448 nm in the
top spectrum of Fig. 3A), would shift the band toward 1,965 cm1
(25). In the region below 1,800 cm1, numerous difference bands
appear (red spectrum in Fig. 3B). The absorbance changes are
much bigger than those observed for photodissociation of CO
from fully reduced CcO (25), particularly in the amide I (1,650
cm1) and the amide II regions (1,540 cm1) where the peptide
bond has vibrational modes. This fact indicates that conforma-
tional changes of the protein backbone take place during the
E-to-R2 reaction, i.e., when an electron is transferred from heme
a to the binuclear center. Such conformational changes alter the
microenvironment of particular residues. For acidic residues
such as glutamic acid, the modulation can decrease the apparent
pKa and effect proton dissociation. Deprotonation in the E-to-
R2CO transition is indeed observed for E286. A negative band
at 1,745 cm1 appears in the E-R2CO difference spectrum of the
wild-type enzyme (continuous red trace in Fig. 3C) but disap-
pears in the spectrum on mutation of glutamic acid 286 to an
aspartatic acid (E286D; dashed red trace in Fig. 3C). Conse-
quently, this band is assigned to the CAO stretching vibration of
E286. Band fitting reveals that the full width at half maximum
of the 1,745 cm1 band is 8 cm1. This value is almost identical
to that of the CAO stretch of D96 of bacteriorhodopsin, i.e., 9
cm1, observed for the N-BR difference spectrum of the E194Q
mutant (26). This agreement supports the finding that the
negative band at 1,745 cm1 in Fig. 3C is solely attributable to
the deprotonation of E286. A conformational change of this
residue would lead to a sigmoidal shaped band feature where the
apparent band width of the negative part is 5 cm1. Even
stronger evidence in favor of a deprotonation would be the
assignment of the vibrational modes of the corresponding car-
boxylate. However, the symmetric and asymmetric carboxylate
modes at 1,300–1,420 cm1 and 1,550–1,610 cm1, respectively,
are difficult to disentangle because of the strong overlap with
other bands in these frequency domains (27). These consider-
Fig. 3. Difference spectroscopy of the reaction intermediates of CcO. (A) Absorption difference spectra in the visible wavelength range. The two-electron
reduced CO-bound state (R2CO) was generated by bubbling CO through a detergent solubilized solution of CcO. The visible spectrum (red trace) exhibits
characteristic maxima at 590 nm of the -band and at 432 nm in the Soret region. The shoulder on the latter band at 448 nm indicates some overreduction after
the time-resolved IR experiments. Pm was created by applying a saturated solution of equimolar amounts of CO and O2 to a protein–lipid film adhered to the
inner surface of a quartz cuvette. The corresponding difference spectrum (Pm-O, middle trace) shows positive bands at 437 and 607 nm. F was established by the
action of H2O2 on the protein-lipid film. The F-O difference spectrum (black trace, bottom) shows characteristic maxima at 434 and 580 nm. (B) Infrared spectra
of CcO from R. sphaeroides, showing the E-R2CO (red trace, top), Pm-O (blue trace, middle), and F-O (black trace, bottom) differences. (C) Enlarged view (10)
of the difference bands of wild-type CcO in the region where carbonyl vibrations of protonated carboxylic acids are expected. The dashed spectra are the
corresponding spectra of the E286D mutant measured under identical conditions. The dashed vertical line indicates the frequency of the CAO stretching
vibration of the carboxylic acid side chain of E286. For comparison, the change in the carbonyl stretch of E286 in the transition from the oxidized to the fully
reduced state (R4-O) is shown in green [top traces; the fully reduced state has been prepared as published (20) but at pH 8.5].







ations also apply to the Pm-O difference spectrum discussed
below. The possible presence of overreduced protein does not
influence the conclusion of the deprotonation of E286 because
the fully reduced enzyme does not exhibit any changes in the
region around 1,745 cm1 (25).
The exchange from glutamic to aspartic acid usually leads to
a frequency shift of the CAO stretch which is indeed observed
in the fully reduced-minus-oxidized (R4-O) difference spectrum
of the R. sphaeroides E286D oxidase (green traces in Fig. 3C; see
(20) for a more detailed description). The R4-O difference
spectrum of the wild-type CcO (continuous green trace in Fig.
3C) reveals that this transition involves only a change in hydro-
gen bonding (20). Such a shift is not observed, however, in the
E-R2CO difference spectrum (red trace in Fig. 3C). Because the
CAO difference band of D286 is small in the R4-O difference
(dashed green trace in Fig. 3C), the corresponding band may be
below the detection limit of the E-R2CO difference experiment.
Nevertheless, it seems that the exact location of the carboxylic
group at position 286 is very critical for the kinetics of proton
pumping in CcO. It is important to note that the E286D mutant,
although somewhat slower than the wild-type enzyme, appears
fully functional and pumps protons (28). The R2CO-to-E tran-
sition has been shown to be associated with proton release from
the enzyme (28). Because proton release is supposed to take
place also from the E286Q mutant (29), E286 cannot be the
origin of the proton but a proton from a different group is
released to the external medium.We attribute the deprotonation
observed in the E-R2CO IR experiments to an internal transfer
of the E286 proton to an unidentified proton acceptor on
electron transfer from heme a3 to heme a.
The E-R2CO difference spectrum of the R. sphaeroides en-
zyme (red trace in Fig. 3B) agrees well with that reported for the
CcO from P. denitrificans (30). However, we assign the negative
band specifically to the deprotonation of E286 rather than to an
unspecified conformational change. Our experiments demon-
strate that E286 is deprotonated in state E and is reprotonated
when an electron is transferred from hemea to hemea3. Amide
difference bands indicate that significant protein backbone
changes accompany this transition.
The Pm-to-O Transition. Vibrational differences for intermediates
Pm and F were examined with ATR technique, which employs a
protein sample in contact with buffer that can be exchanged (20).
Perfusion of CcO with buffers of differing chemical composition
enables stable steady-state generation of oxygen intermediates
Pm and F. Pm was trapped by applying a saturated solution of
equimolar amounts of CO and O2. The establishment of the
reaction intermediate was again verified by visible absorbance
spectroscopy (Fig. 3A, blue middle trace) with characteristic
difference bands at 607 nm () and at 414 ()439 nm () (31).
The corresponding IR difference spectrum acquired with the
perfusion-induced ATR technique is presented in Fig. 3B (blue
middle trace). This spectrum essentially agrees with that previ-
ously observed for bovine CcO (21), although no role for
glutamic acid E286 could be definitively concluded from that
work. We are clearly able to detect a negative band at 1,745 cm1
of the Pm-O difference spectrum (blue continuous trace in Fig.
3C), which downshifts in D2O by 6 cm1 (data not shown), as
expected for a carboxylic acid. The assignment was again per-
formed with the E286D mutant and, as was the case for the
E-R2CO difference spectrum, the signal at 1,745 cm1 disap-
pears (blue dashed trace in Fig. 3C). The absence of significant
positive features in this wavelength range signifies that E286
deprotonates during the transition from O to Pm.
It is expected that the active site tyrosine (Y288) forms a
neutral radical in state Pm. Results from EPR (32) and radio-
active iodide labeling experiments (4) have supported this
conclusion. It should be stressed that IR spectroscopy is not the
optimal method to detect radicals in a protein. However, three
positive bands in the Pm-O difference spectrum indicate the
presence of a tyrosine radical in Pm. The 1,587-cm1 band
concurs with the CAC stretching vibration observed at 1,587
cm1 in the deprotonated neutral radical form of ortho-
imidazole-bound para-cresol, a model compound for the cross-
linked histidine–tyrosine (33). Either of the two positive bands
at 1,528 cm1 and 1,517 cm1 in the Pm-O difference spectrum
can be assigned to the C–C stretch of the radical form of
cross-linked histidine-phenol observed at 1,522 cm1 (34). The
1,479-cm1 band could correspond to the COO stretch of a
tyrosyl radical of Y288 (35). Bands at similar frequency have also
been observed in the radical forms of model compounds (33, 34).
However, it must be noted that although these bands are
consistent with the formation of a tyrosyl radical, contributions
from vibrations of a variety of other groups, in particular from
heme modes, cannot be excluded. Similar features are also
present in the Pm-O difference spectrum of the bovine enzyme
(21), subject to the same uncertainties.
It should be noted that time-resolved visible absorption
spectroscopy studies (28, 29) have examined the P-to-F and
F-to-O transitions in the reaction of the fully reduced oxidase
with O2. The data suggest that proton transfer from E286 is
rate-limiting in each of these steps. However, the P interme-
diate in this reaction, termed Pr, differs from Pm in that the
heme–copper binuclear center is reduced by one more elec-
tron. The active-site tyrosine is thought not to be a neutral
radical in the Pr state, but to be reduced to either tyrosine or
tyrosinate (36). Hence, because the electron distribution is
different for these two versions of the P intermediate, the
protonation state of residues (E286 in particular) may also be
different in Pr and Pm.
The F-to-O Transition.Although the Pm and F states of the enzyme
both have oxoferryl structure (Fe4a3AO2), their resonance-
Raman and visible absorbance spectra differ considerably (37).
F can be generated by exposing a solution of fully oxidized
protein (state O) to an excess of H2O2. When formed under
alkaline conditions, the H2O2-generated F intermediate has a
visible absorbance band at 580 nm (24). The black spectrum in
Fig. 3A demonstrates that F is established under the conditions
used for perfusion-induced IR difference spectroscopy. The
corresponding IR difference spectrum (black trace at the bottom
of Fig. 3B) of F shows spectral changes as small as those of the
O to Pm transition (blue trace). The most obvious difference
between these two spectra is the absence of a negative band at
1,745 cm1 in the F-O difference spectrum (Fig. 3C). Because
E286 is protonated in state O (20), the absence of a change in
the E286 vibration in the F-O difference spectrum indicates that
E286 is protonated in F. It is therefore concluded that E286 is
reprotonated during the Pm to F transition.
The strongest difference band in the F-O spectrum is the sharp
negative band at 1,515 cm1 (black trace in Figs. 3B and 4). This
band matches with the frequency expected for the phenyl ring
stretching mode of protonated tyrosine, which downshifts by 16
cm1 on formation of the tyrosinate (38). Indeed, there is a
positive band (i.e., associated with state F) at 1,499 cm1, which
is D2O-insensitive, as expected if this features is caused by a
tyrosinatetyrosine (FO) transition (Fig. 4, red trace). More-
over, the direct comparison to the pH-induced difference spec-
trum of the free amino acid tyrosine reveals that there is also
another band, namely at 1,248 cm1, that coincides with a
pH-sensitive tyrosine vibration (Fig. 4, green trace). Character-
istically, the phenyl stretch at 1,515 cm1 is down-shifted by only
2 cm1 in D2O (red trace), whereas the band at 1,249 cm1 is
up-shifted by 14 cm1 because the coupling to the CO-H bending
is removed on HD exchange leaving the pure COO stretch to
be observable at 1,262 cm1 (39). To account for the possible
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presence of a covalent linkage of Y288 to H284, the spectrum of
a model compound is depicted where imidazol is bound via the
N (1) to p-cresol in ortho position (40). Indeed, the strong
negative band at 1,546 cm1, which is not present in the
pH-induced difference spectrum of tyrosine, appears in the IR
absorption spectrum of the model compound (Fig. 4, blue
spectrum). This band has been assigned to a coupled Tyr and His
ring mode with large contributions from the CN of the covalent
bond between both ring systems (40). Although the pH-induced
difference spectrum of the model compound is not yet available,
it is reasonable to assume that the frequency of this mode is
changed on deprotonation of the phenol. Because the bands at
1,515 and 1,455 cm1 of the F–O difference spectrum of CcO
also coincide with bands of the Tyr–His model compound, the
data are in line with the presence of a covalently linked
Y288-H284 as observed for CcO from other organisms (6–8).
However, the recently published structure of CcO from R.
sphaeroides (9) lacks support for this cross-link. Apart from the
tyrosine modes, either cross-linked or not, the F-O difference
spectrum exhibits negative bands 1,687, 1,656, and 1,612 cm1.
These are essentially insensitive to H2OD2O exchange and may
reflect heme modes.
Conclusions
The IR difference spectra presented here are consistent with the
role of E286 as a proton shuttle. Taken together, the IR data
indicate that E286 changes its protonation state at least four
times during the course of the cycle. The residue(s) playing the
role of proton donor and acceptor may be different for different
transitions, and they remain as yet unidentified. The pumping
steps from E-to-R2 and Pm-to-F occur from a state where E286
is deprotonated whereas the pumping step from F-to-O occurs
from a state where E286 is apparently protonated. This dem-
onstrates the fact that proton pumping clearly cannot be ex-
plained by the protonation state of E286 alone. The roles of
other residues and their sequence of protonation states remain
to be elucidated before this vectorial proton pump can be
understood. The acidity of the E286 side chain is subject to large
changes depending on the redox status of the metal centers. The
shift in the pKa of E286 implies the need for a conformational
change that will result in a stabilization of the deprotonated form
of the glutamate, which is in a hydrophobic environment in both
the O and R2 states of the enzyme. This situation is reminiscent
of that for D96 in bacteriorhodopsin (13, 41), where conforma-
tional changes introduce water to link the residue to enable
proton transfer to the Schiff base and also transiently stabilize
the deprotonated form of D96.
In addition to the central role of E286, the IR difference
spectra provide experimental support for Y288 playing an active
role in catalysis. This tyrosine is protonated in the fully oxidized
enzyme, is a neutral radical in state Pm, and is reduced to the
anionic tyrosinate in state F. The IR data are also consistent with
the presence of the cross-linked histidine-tyrosine in the R.
sphaeroides oxidase.
Based on the status of E286 and Y288 in the various inter-
mediate states, we suggest the following reaction scheme of
catalysis by CcO (Fig. 2). The first electron transfer to reduce
CuB in the E state leads to the dissociation of the bound
hydroxide. The high proton affinity of the OH anion abstracts a
proton fromE286 to formwater. The proton taken up during this
reaction (42), is used in the subsequent reaction step. The second
electron to reduce heme a3 in the E-to-R2 step triggers the
reprotonation of E286. Because proton translocation occurs
during this transition (11), the uptaken proton might be the
translocated one. The conformational change of the protein
backbone, which is deduced from the observed amide I differ-
ences (Fig. 3B red spectrum), initiates either of the two proton
transfer reactions. Additionally, it is quite plausible that an
electrostatic rearrangement drives the changes in protonation
state (43). The R2-to-Pm transition is accompanied by neither
proton uptake nor translocation. However, binding and fission of
dioxygen drives internal proton rearrangements, such as depro-
tonation of E286 and Y288, the latter becoming a radical. Of the
two protons, one is required for the establishment of the
proposed hydroxy ligand of CuB. The other may be transferred
to a residue of the proton exit pathway, such as the ring D
propionate of heme a3 (9). The third electron transforms the
radical of Y288 into the phenolate. The uptake of a proton
during the lifetime of the F intermediate instigates the repro-
tonation of E286. Proton release to the extracellular surface
takes place from the aforementioned residue of the exit pathway.
Thus, proton translocation is accomplished during the Pm-to-F
transition. In the final reaction steps from F to O, the fourth
electron reduces heme a3. Concomitant protonation of the
oxo-ferryl shifts the hydroxy ligand to CuB. Associated with these
steps are reprotonation of Y288 to form the phenolic tyrosine
and vectorial proton translocation across the protein.
Finally, it is important to point out that the states examined
in the current work, E, Pm, F and O, are really starting and
ending points of electron transfer-induced transitions that
result in proton pumping. The states that are critically involved
in proton pumping are the transient states that form during
these transitions, such as from F to O. Virtually nothing is
known about these states of CcO. The current work is a
significant step along the way toward defining the spectro-
scopic features needed to exploit time-resolved Fourier trans-
form IR spectroscopy which will ultimately reveal the dynam-
ics of the proton pump in action.
We are grateful to W.Woodruff (Los Alamos, NM) for providing the IR
spectrum of the Tyr–His model compound and for helpful discussions.
This work was supported National Institutes of Health Grant HL16101
(to R.B.G.) and Training Grant 5-T32GMO8276-13 (to R.M.N.), a grant
from the Deutscher Akademischer Austauschdienst (to R.M.N.), Deut-
sche Forschungsgemeinschaft Grant SFB-189, Project C6 (to J.H.), and
a grant from the Volkswagen Foundation (to J.H.).
Fig. 4. Infrared F-O difference spectra of CcO compared with the pH-induced
difference of tyrosine. The red trace is the F-O difference in D2O. The black
trace corresponds to the sample measurement in H2O (same as in Fig. 3B but
displayed across a broader frequency range and enlarged in the absorbance
axis). The green spectrum is the vibrational difference spectrum between a 2
mM solution of tyrosine at pH 12 (Tyr-O) and pH 8 (Tyr-OH). The IR spectrum
of the synthetic compound 2-(4-methyl-1H-imidazol-1-yl)-4-methylphenol,
which models the covalently linked amino acids Y288-H284, is depicted in
blue. Data have kindly been provided by W. Woodruff (see ref. 40 for details).
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